Abstract
We review current approaches that can extend our understanding of monogenic disease towards complex disease. Recent studies showed that currently established disease genes differ in their protein size, tissue specificity and the phylogenetic distribution of homologs. These characteristics can be explained by the fact that monogenic disease mutations must be sufficiently deleterious to produce a clearly recognizable phenotype, but also must not be lethal in an early embryonic stage. On the other hand, deletion of each gene in the human genome must be evolutionarily disadvantageous. For most genes, this disadvantage might manifest as an increased susceptibility to complex disease. Accordingly, mildly deleterious variants can be observed in a wide spectrum of genes. The phenotypic manifestation of these mildly deleterious variants might depend on somatic mutations, which cause the breakdown of compensating mechanisms in individual cells. At present, association studies are the most promising strategy for mapping complex disease phenotypes. However, these are restricted to the identification of common disease variants and often provide only marginally convincing statistical evidence. Novel computational strategies, which take prior biological knowledge into account, therefore might play a major role in the design and interpretation of large-scale association studies.
Keywords: human genes, phenotype, genome sequence, HapMap project, genetic variants
Current Genomics
Title: Approaching Inherited Disease on a Genomic Scale
Volume: 6 Issue: 7
Author(s): Jan Freudenberg, Ying-Hui Fu and Louis J. Ptacek
Affiliation:
Keywords: human genes, phenotype, genome sequence, HapMap project, genetic variants
Abstract: We review current approaches that can extend our understanding of monogenic disease towards complex disease. Recent studies showed that currently established disease genes differ in their protein size, tissue specificity and the phylogenetic distribution of homologs. These characteristics can be explained by the fact that monogenic disease mutations must be sufficiently deleterious to produce a clearly recognizable phenotype, but also must not be lethal in an early embryonic stage. On the other hand, deletion of each gene in the human genome must be evolutionarily disadvantageous. For most genes, this disadvantage might manifest as an increased susceptibility to complex disease. Accordingly, mildly deleterious variants can be observed in a wide spectrum of genes. The phenotypic manifestation of these mildly deleterious variants might depend on somatic mutations, which cause the breakdown of compensating mechanisms in individual cells. At present, association studies are the most promising strategy for mapping complex disease phenotypes. However, these are restricted to the identification of common disease variants and often provide only marginally convincing statistical evidence. Novel computational strategies, which take prior biological knowledge into account, therefore might play a major role in the design and interpretation of large-scale association studies.
Export Options
About this article
Cite this article as:
Freudenberg Jan, Fu Ying-Hui and Ptacek J. Louis, Approaching Inherited Disease on a Genomic Scale, Current Genomics 2005; 6 (7) . https://dx.doi.org/10.2174/138920205775067693
DOI https://dx.doi.org/10.2174/138920205775067693 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) MicroRNAs - Key Players in Haematopoiesis
Current Signal Transduction Therapy Targeting Multiplicity: The Key Factor for Anti-Cancer Nanoparticles
Current Medicinal Chemistry Prostate Cancer Horizons in the Development of Novel Anti-Cancer Strategies
Current Medicinal Chemistry - Anti-Cancer Agents Gene Therapy and Targeted Toxins for Glioma
Current Gene Therapy When Neighbors Talk: Colon Cancer Cell Invasion and Tumor Microenvironment Myofibroblasts
Current Drug Targets Structure and Functional Relationships of Hsp90
Current Cancer Drug Targets Blocking Ca2+ Entry: A Way to Control Cell Proliferation
Current Medicinal Chemistry Multiple Forms of Proteasomes and their Role in Tumor Fate
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies
Current Drug Targets Amaranth: A Pseudo-Cereal with Nutraceutical Properties
Current Nutrition & Food Science Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?
Current Drug Targets Microenvironmental Regulation of Cancer Stem Cell Phenotypes
Current Stem Cell Research & Therapy Recent Progress in Research on Ribosome Inactivating Proteins
Current Protein & Peptide Science Recent Developments in the Virology and Antiviral Research of Severe Acute Respiratory Syndrome Coronavirus
Infectious Disorders - Drug Targets A Common Biological Mechanism in Cancer and Alzheimers Disease?
Current Alzheimer Research Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer
Current Drug Targets Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases
Current Signal Transduction Therapy Medulloblastoma: Role of Developmental Pathways, DNA Repair Signaling, and Other Players
Current Molecular Medicine